hero section gradient
13 handpicked stocks

Cyber Security

Your cyber safety is these companies' priority. Explore this carefully selected group of stocks that protect our digital world, chosen by professional analysts tracking the rapidly expanding cybersecurity market.

Author avatar

Han Tan | Market Analyst

Published on May 6

Your Basket's Financial Footprint

Summary of total market capitalisation and concentration among largest constituents for the Cyber Security basket.

Key Takeaways for Investors:
  • Large-cap concentration generally reduces volatility; performance likely mirrors broad-market movements rather than idiosyncratic swings.
  • Best viewed as a core holding within a diversified portfolio, not a speculative or short-term growth play.
  • Expect likely steady, long-term value appreciation rather than frequent, explosive short-term gains.
Total Market Cap
  • PANW: $145.12B

  • CSCO: $279.57B

  • FTNT: $64.96B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Cybersecurity is essential in our increasingly digital world. With the market expected to grow 10.9% annually to $366 billion by 2028, these companies are at the forefront of protecting digital infrastructure as businesses and consumers face evolving threats.

2

What You Need to Know

The cybersecurity sector benefits from consistent demand driven by digital transformation, remote work trends, and rising cyber attacks. These stocks represent a mix of established industry leaders and innovative solution providers across network, cloud, and identity security.

3

Why These Stocks

We've selected companies with strong market positions across different cybersecurity niches. From SaaS models like Okta and Docusign to network security experts like Cisco and Juniper, these stocks represent the diverse ecosystem protecting our digital landscape.

Why You'll Want to Watch These Stocks

🚀

Riding the Digital Security Wave

With cybersecurity spending projected to reach $366 billion by 2028, these companies are positioned to benefit from the massive 10.9% annual growth as digital threats continue to evolve.

🔐

Essential in Every Business Budget

Cybersecurity isn't optional anymore. As digital attacks become more sophisticated, companies must increase their security budgets, creating consistent demand for these service providers.

💼

The Pandemic-Proof Portfolio Addition

Remote work and digital transformation accelerated by COVID-19 created permanent new security needs. These companies offer solutions that have become essential infrastructure for the modern economy.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions